| Deana L Dy, MD | |
|
25 S Virginia St, Suite 203, Crystal Lake, IL 60014-5800 | |
| (815) 459-5440 | |
| Not Available |
| Full Name | Deana L Dy |
|---|---|
| Gender | Female |
| Speciality | Allergy & Immunology |
| Location | 25 S Virginia St, Crystal Lake, Illinois |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1518950781 | NPI | - | NPPES |
| BCBS4901048 | Other | IL | BCBS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207K00000X | Allergy & Immunology | 036-057986 (Illinois) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Deana L Dy, MD 25 S Virginia St, Crystal Lake, IL 60014-5800 Ph: (815) 459-5440 | Deana L Dy, MD 25 S Virginia St, Suite 203, Crystal Lake, IL 60014-5800 Ph: (815) 459-5440 |
News Archive
Raptor Pharmaceutical Corp., today announced it has completed enrollment in its Phase 3 clinical trial of its proprietary delayed-release oral formulation of cysteamine bitartrate ("DR Cysteamine") in patients with nephropathic cystinosis ("cystinosis").
A new paper in the British Journal of Surgery, published by Oxford University Press, indicates it's now possible to diagnose appendicitis using low-does CT scans, decreasing the radiation exposure, which is of significant clinical importance especially in young patients.
Coupling an electronic prescription drug ordering system with a computerized method for reporting adverse events can dramatically reduce the number of medication errors in a hospital's psychiatric unit, suggests new Johns Hopkins research.
On July 24, 2009, The NASDAQ Stock Market notified Commonwealth Biotechnologies, Inc. that CBI was to be delisted from the NASDAQ Capital Market as a result of a failure to comply with NASDAQ Listing Rule 5550(b) due to a failure to maintain minimum stockholders' equity of $2.5 million and a failure to file a Form 8-K affirming compliance with Rule 5550(b).
A new study in Neuron offers clues to why autism spectrum disorder is more common in boys than in girls. National Institutes of Health scientists found that a single amino acid change in the NLGN4 gene, which has been linked to autism symptoms, may drive this difference in some cases.
› Verified 3 days ago
Dr. Noga Askenazi, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 730 E Terra Cotta Ave, Ste A, Crystal Lake, IL 60014 Phone: 847-888-8802 Fax: 866-246-1164 |